BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29931440)

  • 1. Utility of contrast-enhanced ultrasonography with perflubutane in evaluating indications for diagnostic percutaneous tumor biopsy in a case of hepatic sclerosed hemangioma.
    Ando Y; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hirooka Y
    Clin J Gastroenterol; 2018 Dec; 11(6):514-520. PubMed ID: 29931440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Sclerosed Hemangioma: a case report and review of the literature.
    Miyamoto S; Oshita A; Daimaru Y; Sasaki M; Ohdan H; Nakamitsu A
    BMC Surg; 2015 Apr; 15():45. PubMed ID: 25927893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cavernous hemangioma of the liver: role of percutaneous biopsy.
    Cronan JJ; Esparza AR; Dorfman GS; Ridlen MS; Paolella LP
    Radiology; 1988 Jan; 166(1 Pt 1):135-8. PubMed ID: 3275965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hepatic sclerosed hemangioma with drastic changes in contrast-enhanced ultrasonography.
    Akahoshi S; Yamamura K; Sato N; Oda E; Kinoshita K; Yuki H; Motohara T; Deguchi A; Komohara Y; Beppu T
    Clin J Gastroenterol; 2020 Dec; 13(6):1252-1257. PubMed ID: 32705537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of sclerosed hemangioma mimicking intrahepatic cholangiocarcinoma].
    Park SM; Shin SM; Seo HE; Kim SH; Kim HS; Park JH; Kim JH; Sohn KR
    Korean J Gastroenterol; 2009 Dec; 54(6):399-403. PubMed ID: 20026896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of hepatic cavernous hemangioma by fine needle aspiration biopsy under ultrasonic guidance.
    Nakaizumi A; Iishi H; Yamamoto R; Kasugai H; Tatsuta M; Okuda S; Kishigami Y; Kitamura T
    Gastrointest Radiol; 1990; 15(1):39-42. PubMed ID: 2404823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound (CEUS) for the diagnosis of hypoechoic hepatic hemangioma in clinical practice.
    Fang L; Huang BJ; Ding H; Mao F; Li CL; Zeng MS; Zhou JJ; Chen Y; Wang WP
    Clin Hemorheol Microcirc; 2019; 72(4):395-405. PubMed ID: 30909196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of contrast-enhanced ultrasound to increase the diagnostic rate of liver tumor by biopsy].
    Wu W; Chen MH; Yan K; Yin SS; Dai Y; Fan ZH; Yang W; Li JY
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):116-20. PubMed ID: 16620718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of Hepatic Sclerosed Hemangiomas From Cavernous Hemangiomas Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features.
    Hwang JA; Kang TW; Cha DI; Kim SH; Ha SY; Kim SW
    J Comput Assist Tomogr; 2019; 43(5):762-769. PubMed ID: 31356526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significant regression of a cavernous hepatic hemangioma to a sclerosed hemangioma over 12 years: a case study].
    Miyaki D; Aikata H; Waki K; Murakami E; Hashimoto Y; Nagaoki Y; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Imamura M; Takahashi S; Ohya T; Sakimoto H; Arihiro K; Chayama K
    Nihon Shokakibyo Gakkai Zasshi; 2011 Jun; 108(6):954-61. PubMed ID: 21646763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.
    Nuta J; Shingaki N; Ida Y; Shimizu R; Hayami S; Ueno M; Fukatsu K; Itonaga M; Yoshida T; Maeda Y; Moribata K; Deguchi H; Maekita T; Iguchi M; Kato J; Yamaue H; Tamai H
    Ultrasound Med Biol; 2017 Sep; 43(9):1829-1836. PubMed ID: 28625558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
    Ultrasound Med Biol; 2015 Dec; 41(12):3070-8. PubMed ID: 26360976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypically enhanced cavernous hemangiomas of the liver: centrifugal enhancement does not preclude the diagnosis of hepatic hemangioma.
    Matsushita M; Takehara Y; Nasu H; Hirai Y; Yamashita S; Souda K; Kobayashi Y; Miura K
    J Gastroenterol; 2006 Dec; 41(12):1227-30. PubMed ID: 17287903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative diagnosis of the sclerosed hemangioma of the liver using multimodality imaging findings: A case report.
    Ozaki K; Yoshikawa J; Yamamoto T; Maeda K; Kaizaki Y
    Radiol Case Rep; 2018 Oct; 13(5):1025-1029. PubMed ID: 30228837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of contrast enhanced ultrasound and contrast enhanced magnetic resonance imaging for the detection and characterization of hepatic hemangiomas.
    Fang L; Zhu Z; Huang B; Ding H; Mao F; Li C; Zeng M; Zhou J; Wang L; Wang W; Chen Y
    Biosci Trends; 2015 Apr; 9(2):104-10. PubMed ID: 25971695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
    Numata K; Fukuda H; Nihonmatsu H; Kondo M; Nozaki A; Chuma M; Morimoto M; Oshima T; Okada M; Murakami T; Takebayashi S; Maeda S; Inayama Y; Nakano M; Tanaka K
    Abdom Imaging; 2015 Oct; 40(7):2372-83. PubMed ID: 26099473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.